2 ml vial of tirzepatide 159.00 | --- 36 mg / --- 2 ml --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) tirzepatide by eli lilly Eli

Consider timing other medications carefully If you take other medications, its important to be mindful of their timing in relation to semaglutide

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related conditions (Zepbound)

Plenty of protein: Protein also stimulates the release of GLP-1

This overlapping approach allows the new medication time to reach therapeutic levels before GLP-1 support is fully withdrawn

Gynecol Oncol 6:373382 Doyle LA, Marino-Enriquez A, Fletcher CD et al (2015) ALK rearrangement and overexpression in epithelioid fibrous histiocytoma